Johnson & Johnson Innovation - JJDC, Inc.
Known title: 10% OwnerCIK: 0000924020
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
CVRx Appoints John Landry as CFO. CVRx announced that John Landry will become chief financial officer, effective Oct. 12, replacing Jared Oasheim. The change follows a routine leadership transition and may bring new financial oversight to the company. The appointment is noted by market watchers but does not alter the current trading range or technical signals. Investors can monitor how the new CFO’s approach aligns with the company’s financial goals.
Transaction History
| MGTX | ▼ Sell | Other | 6,641,064 | — | 9/15/2023 | View on chart |
| CVRX | ▼ Sell | Other | 3,495,575 | — | 9/15/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Goldman Sachs initiates MeiraGTx coverage with Neutral rating
Goldman Sachs has started covering MeiraGTx, assigning a Neutral rating and a price target of $16. This new analyst view comes as the company also appointed Alan M. Sebulsky to its board of directors. The stock is currently trading near its 52-week low, providing context for the firm's initial assessment.
Goldman Sachs initiates MeiraGTx coverage with Neutral rating. Goldman Sachs has started covering MeiraGTx, assigning a Neutral rating and a price target of $16. This new analyst view comes as the company also appointed Alan M. Sebulsky to its board of directors. The stock is currently trading near its 52-week low, providing context for the firm's initial assessment.